Viewing Study NCT06015503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-21 @ 6:46 PM
Study NCT ID: NCT06015503
Status: RECRUITING
Last Update Posted: 2025-04-03
First Post: 2023-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)
Sponsor: Avistone Biotechnology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small-Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small-Cell Lung Cancer View
None EGFR View
None NSCLC View
None Lung Cancer View